Understanding Rural Patient and Provide Preferences for Mobile Lung Cancer Screening Clinics

Lung Cancer Clinical Trial

Official title:

Understanding Rural Patient and Provide Preferences for Mobile Lung Cancer Screening Clinics

Clinical Trial Details — Status: Recruiting

Administrative data

• NCT number: NCT04926662
• Other study ID #: D21031
• Status: Recruiting
• Start date: July 14, 2021
• Est. completion date: June 1, 2027

Study information

• Verified date: June 2023
• Source: Dartmouth-Hitchcock Medical Center
• Contact: Rian Hasson, MD
• Phone: 603-650-8537
• Email: Rian.M.Hasson[@]hitchcock.org
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to research patient preferences for lung cancer screening and pilot mobile units to address the barrier of access that decreases participation in lung cancer screening.

Description:

The overarching goal of this study is to research patient preferences for lung cancer screening and pilot mobile units to address the barrier of access that decreases participation in lung cancer screening. To facilitate this, the investigators will evaluate the feasibility of mobile lung cancer screening clinics to improve access through focus group study in designated rural areas of New Hampshire and Vermont, canvas and survey these areas to confirm need, and pilot the mobile lung cancer screening clinic to establish practicability. Findings from the proposed project will be used as preliminary data to apply for further funding and to implement the mobile unit in these identified rural communities on a consistent basis.

Recruitment information / eligibility

• Status: Recruiting
• Enrollment: 320
• Est. completion date: June 1, 2027
• Est. primary completion date: January 1, 2027
• Accepts healthy volunteers: No
• Gender: All
• Age group: 50 Years to 80 Years

Eligibility

Inclusion Criteria:

• Adults age 50 to 80 years old

• 20 pack-year smoking history who are currently smoking or have quit smoking within the last 15 years

Exclusion Criteria:

-

Related Conditions & MeSH terms

• Lung Cancer
• Lung Neoplasms

Locations

Country	Name	City	State
United States	Dartmouth-Hitchcock Medical Center	Lebanon	Ohio

Sponsors (1)

Lead Sponsor	Collaborator
Dartmouth-Hitchcock Medical Center

Country where clinical trial is conducted

United States, 

References & Publications (6)

Atkins GT, Kim T, Munson J. Residence in Rural Areas of the United States and Lung Cancer Mortality. Disease Incidence, Treatment Disparities, and Stage-Specific Survival. Ann Am Thorac Soc. 2017 Mar;14(3):403-411. doi: 10.1513/AnnalsATS.201606-469OC. — View Citation

Bhatt S, Isaac R, Finkel M, Evans J, Grant L, Paul B, Weller D. Mobile technology and cancer screening: Lessons from rural India. J Glob Health. 2018 Dec;8(2):020421. doi: 10.7189/jogh.08.020421. — View Citation

Brenner AT, Malo TL, Margolis M, Elston Lafata J, James S, Vu MB, Reuland DS. Evaluating Shared Decision Making for Lung Cancer Screening. JAMA Intern Med. 2018 Oct 1;178(10):1311-1316. doi: 10.1001/jamainternmed.2018.3054. — View Citation

Greenwald ZR, El-Zein M, Bouten S, Ensha H, Vazquez FL, Franco EL. Mobile Screening Units for the Early Detection of Cancer: A Systematic Review. Cancer Epidemiol Biomarkers Prev. 2017 Dec;26(12):1679-1694. doi: 10.1158/1055-9965.EPI-17-0454. Epub 2017 Oc — View Citation

Odahowski CL, Zahnd WE, Eberth JM. Challenges and Opportunities for Lung Cancer Screening in Rural America. J Am Coll Radiol. 2019 Apr;16(4 Pt B):590-595. doi: 10.1016/j.jacr.2019.01.001. — View Citation

Vang S, Margolies LR, Jandorf L. Mobile Mammography Participation Among Medically Underserved Women: A Systematic Review. Prev Chronic Dis. 2018 Nov 15;15:E140. doi: 10.5888/pcd15.180291. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Recruitment	Number of individuals recruited to the mobile lung cancer screening units	6 months after starting the mobile lung cancer screening units (Aim 3)
Secondary	Change in knowledge	Change in knowledge before and after entering the mobile lung cancer screening, as determined by the pre and post survey	6 months after starting the mobile lung cancer screening units (Aim 3)